Cheol Moon
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advancements in Transdermal Drug Delivery 6
- Drug Solubulity and Delivery Systems 5
- Advanced Drug Delivery Systems 4
-
- Nanoparticle-Based Drug Delivery 7
- Co-authors
- Victor Chi-Min Yang (12 shared papers)Shin Meong Cheol (14 shared papers)Kyoung Ah Min (12 shared papers)Yoon Jeong Park (4 shared papers)Young Min Kwon (4 shared papers)Yongzhuo Huang (9 shared papers)Euichaul Oh (6 shared papers)Heesun Cheong (8 shared papers)
- Journals
- Journal of Pharmaceutical Investigation (6 papers)Journal of Controlled Release (3 papers)Pharmaceutical Research (2 papers)International Journal of Nanomedicine (2 papers)International Journal of Pharmaceutics (2 papers)
- Partner nations
- South KoreaChinaUnited States
In The Last Decade
Cheol Moon
36 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 86
- Pharmaceutical Science 371
- Biomaterials 350
- Drug Discovery 3
- Toxicology 33
- Molecular Medicine 34
Countries citing papers authored by Cheol Moon
This map shows the geographic impact of Cheol Moon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheol Moon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheol Moon more than expected).
Fields of papers citing papers by Cheol Moon
This network shows the impact of papers produced by Cheol Moon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheol Moon. The network helps show where Cheol Moon may publish in the future.
Co-authors
The 25 scholars most cited alongside Cheol Moon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 113 | |
| 2 | 2005 | 106 | |
| 3 | 2015 | 94 | |
| 4 | 2020 | 93 | |
| 5 | 2007 | 84 | |
| 6 | 2016 | 77 | |
| 7 | 2014 | 75 | |
| 8 | 2009 | 70 | |
| 9 | 2010 | 54 | |
| 10 | 2014 | 48 | |
| 11 | 2021 | 38 | |
| 12 | 2015 | 37 | |
| 13 | 2018 | 35 | |
| 14 | 2007 | 33 | |
| 15 | 2010 | 33 | |
| 16 | 2011 | 33 | |
| 17 | 2016 | 31 | |
| 18 | 2016 | 29 | |
| 19 | 2016 | 27 | |
| 20 | 2017 | 23 |
About Cheol Moon
Cheol Moon is a scholar working on Pharmaceutical Science, Biomaterials, Immunology, Rehabilitation and Molecular Biology, having authored 37 papers that have together received 1.3k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (7 papers), Advancements in Transdermal Drug Delivery (6 papers), RNA Interference and Gene Delivery (5 papers), Drug Solubulity and Delivery Systems (5 papers), Toxin Mechanisms and Immunotoxins (4 papers), Advanced Drug Delivery Systems (4 papers), Microbial Natural Products and Biosynthesis (2 papers) and Pancreatic function and diabetes (2 papers). The work is most often cited by research in Pharmaceutical Science (371 citations), Biomaterials (350 citations), Drug Discovery (3 citations), Toxicology (33 citations) and Molecular Medicine (34 citations). Cheol Moon has collaborated with scholars based in South Korea, China and United States. Frequent co-authors include Victor Chi-Min Yang, Shin Meong Cheol, Kyoung Ah Min, Yoon Jeong Park, Young Min Kwon, Yongzhuo Huang, Euichaul Oh, Heesun Cheong, Allan E. David and Won‐Kyu Lee. Their work appears in journals such as Journal of Pharmaceutical Investigation, Journal of Controlled Release, Pharmaceutical Research, International Journal of Nanomedicine and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.